First Tracks Biotherapeutics TRAX
NASDAQ TRAX
$46.56 -0.54 (-1.15%)
At close: Nov 16, 2026 · 4:00 PM EST

First Tracks Biotherapeutics (TRAX) Capital Expenditures (2025 - 2026)

Updated

Analysis

First Tracks Biotherapeutics (TRAX) Capital Expenditures (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 3.18 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 1.36 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 301.00 Mn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 1.04 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn -3.30 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 587.00 Mn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 237.00 Mn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 573.00 Mn
10 First Tracks Biotherapeutics 1.66 Bn 740.14 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 25,000.00
Mar 31, 2026 17,000.00
Dec 31, 2025 -173,000.00
Sep 30, 2025 12,000.00
Jun 30, 2025 39,000.00
Mar 31, 2025 35,000.00
API Access

First Tracks Biotherapeutics Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=TRAX&period=max&api_key=YOUR_API_KEY